http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2763136-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_320546cc57c27683bd8573def3736be2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
| filingDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bbb371da555c719f0b5d3db5d288030 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f71a86567f0f8bcfa1981b444d80985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5187d2aa74b7542cac5c96390ebda4be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ca11813d5c6aacc46f0aae92c856bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f7c561538843410376be62048d7727 |
| publicationDate | 2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2763136-C1 |
| titleOfInvention | Pharmaceutically acceptable acetyl-(d-lys)-lys-arg-arg-amide peptide salts |
| abstract | FIELD: biochemistry. n SUBSTANCE: invention relates to the field of biochemistry and pharmacology, in particular to the pharmaceutically acceptable salt of the peptide acetyl-(D-Lys)-Lys-Arg-Arg-amide, as well as to pharmaceutical compositions that contain it. An acetyl-(D-Lys)-Lys-Arg-Arg-amide peptide salt selected from hydrochloride and phosphate salts is proposed. The salt of the present invention is soluble in water at a concentration of at least 1%, which makes it possible to obtain a solution for the preparation of a drug with greater stability during storage than the previously known acetate salt of the peptide, does not have a pronounced sharp or unpleasant odor and is suitable for the preparation of a drug for the treatment of Alzheimer’s disease and depression in the form of a dosed nasal spray. n EFFECT: expansion of the range of medicines against Alzheimer’s disease. n 7 cl, 5 dwg, 1 tbl, 3 ex |
| priorityDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.